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Cell death exists in many different forms. Some are accidental, but most of them
have some kind of regulation and are called programmed cell death. Programmed
cell death (PCD) is a very diverse and complex mechanism and must be tightly
regulated. This study investigated PCD induced by DFNA5, a gene responsible for
autosomal dominant hearing loss (HL) and a tumor suppressor gene (TSG) involved
in frequent forms of cancer. Mutations in DFNA5 lead to exon 8 skipping and result
in HL in several families. Expression of mutant DFNA5, a cDNA construct where exon
8 is deleted, was linked to PCD both in human cell lines and in Saccharomyces
cerevisiae. To further investigate the cell death mechanism induced by mutant DFNA5,
we performed a microarray study in both models. We used wild-type DFNA5,which does
not induce cell death, as a reference. Our data showed that the yeast pathways related
to mitochondrial ATP-coupled electron transport chain, oxidative phosphorylation and
energy metabolism were up-regulated, while in human cell lines, MAP kinase-related
activity was up-regulated. Inhibition of this pathway was able to partially attenuate
the resulting cell death induced by mutant DFNA5 in human cell lines. In yeast, the
association with mitochondria was demonstrated by up-regulation of several cytochrome
c oxidase (COX) genes involved in the cellular oxidative stress production. Both models
show a down-regulation of protein sorting- and folding-related mechanisms suggesting
an additional role for the endoplasmic reticulum (ER). The exact relationship between ER
and mitochondria in DFNA5-induced cell death remains unknown at this moment, but
these results suggest a potential link between the two.
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Introduction
Cell death is a fundamental process of all organisms and inherent to life. The role of programmed
cell death (PCD) in the pathology of hearing loss (HL) has been well studied and seems to play a
prominent role, especially in the development of the vertebrate inner ear and in the morphogenesis
of the semicircular canals (Fekete et al., 1997; Nishikori et al., 1999; Leon et al., 2004). Several
genes related to PCD-induced HL have been identified and many of these are related to the
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mitochondria (Estivill et al., 1998; Jacobs et al., 2005; Ding et al.,
2013).Mitochondria are key players during PCD and dysfunction
of the mitochondria has been linked to the pathogenesis of many
diseases, including HL. Mitochondria are the main producers
of cellular ATP due to oxidative phosphorylation. However, this
process also generates reactive oxygen species (ROS) (Raha and
Robinson, 2000). Due to the mitochondrial production of ROS,
the reduced DNA repair capacity and the close proximity of
mtDNA to ROS generation sites, mtDNA (mitochondrial DNA)
is very susceptible to mutations. Enhanced oxidative stress will
have detrimental effects on cellular health and plays a major role
during aging, mutagenesis, and cell death (Gredilla and Barja,
2005; Maynard et al., 2009; Gredilla et al., 2010).
Due to the relative slow speech perception detoriation, it is
assumed that DFNA5-related HL is due to cochlear dysfunction.
The cochlea seems to be highly susceptible to the detrimental
effects of mitochondrial damage due to the post-mitotic character
of its sensory epithelium (Sha et al., 2001).
It is estimated that in the Caucasian population at least 5%
of the post-lingual non-syndromic HL is due to mutations in
the mtDNA (Estivill et al., 1998; Jacobs et al., 2005). Most
mutations in mtDNA affect the mitochondrialMTRNR1 and the
MTTS1 genes encoding respectively a mitochondrial 12S rRNA
and a tRNASer. Mutations in these mitochondrial genes lead to
variable clinical severity of HL due to impaired mitochondrial
tRNA metabolism and protein synthesis (Casano et al., 1999;
Fischel-Ghodsian, 1999; Jin et al., 2007; Ding et al., 2013;
Dowlati et al., 2013). Also many of the nuclear DNA mutations
leading to HL are related to mitochondrial dysfunction and PCD.
These include genes such as OPA1, TIMM8A, SMAC/DIABLO,
MPV17, PDSS1, BCS1L, SUCLA2, C10ORF2, COX10, PLOG1,
and RRM2B (Roesch et al., 2002; Antonicka et al., 2003; Payne
et al., 2004; Mollet et al., 2007; Cheng et al., 2011; Meyer
Zum Gottesberge et al., 2012; Luo et al., 2013). These genes
contribute to various fundamental mitochondrial aspects, such as
mitochondrial protein transport, mitochondrial fragmentation,
and oxidative phosphorylation. Mutations in these genes are
thought to induce mitochondrial stress and trigger cell death in
the cochlea leading to HL. The explanation for the tissue specific
effect of these genes leading to more prominent cell death in the
cochlea and the hair cells remains unknown at this moment.
In addition to the genes directly associated with the
mitochondria, two other genes related to apoptosis, a specific
form of PCD, have been linked with hearing loss. MSBR3, a
gene encoding a methionine sulfoxide reductase, is associated
with caspase-3 activity. This can initiate apoptosis, eventually
leading to degeneration of the inner hair cells and recessive non-
syndromic HL (Ahmed et al., 2011). Overexpression of the TJP2
gene, due to a genomic duplication, altered the expression of
several apoptotic genes, inducing a dominant non-syndromic
form of HL (Walsh et al., 2010).
From these examples, it is clear that a prominent association
exists between (mitochondria-related) PCD and non-syndromic
HL. Many forms of HL, such as age-related hearing impairment
(ARHI), noise-induced hearing loss (NIHL), monogenic forms
of HL and ototoxicity, have been associated with dysfunctional
mitochondria and PCD, underscoring the importance and the
need to further investigate the role of PCD in the pathogenesis
of deafness (Casano et al., 1999; Sha et al., 2009; Someya et al.,
2009; Liu et al., 2010; Chen et al., 2012).
One of the monogenic deafness genes that is related to PCD is
DFNA5. DFNA5 was originally identified as a gene responsible
for an autosomal dominant form of HL in a Dutch family
(Van Laer et al., 1998). Today, eight families with mutations in
DFNA5 (mutDFNA5) associated with HL have been identified.
The phenotype of the HL is very similar with the exception of
the age-of-onset which varies from 15 to 50 years old. The HL
is symmetric and starts in the high frequencies, but spreads to
the lower frequencies in a later stage. Four of the eight mutations
differ at the genomic level, but they all result in skipping of
exon 8, yielding an immature truncated protein (Yu et al., 2003;
Bischoff et al., 2004; Cheng et al., 2007; Park et al., 2010; Nishio
et al., 2014). The structure of DFNA5 is unknown at this moment,
but hydrophobic cluster analysis revealed that DFNA5 consists
of two regions, domain A and domain B, connected by a hinge
region (Op de Beeck et al., 2011). Mutations in DFNA5 result in
a truncated protein lacking the last part of domain B due to a
premature stop codon. This premature stop codon is caused by
skipping of exon 8 as a result of the different genomic mutations
in DFNA5 present in the families. Op de Beeck et al. (2011) have
also demonstrated that only the first part, domain A, present in
both wild-type and mutDFNA5, is sufficient to induce cell death
after transfection in human cell lines. Domain B did not have
any cell death inducing capacity. This led to the hypothesis that
domain B will normally shield this cell death-inducing domain
A to avoid inappropriate activation of domain A. Due to the
partial lack of domain B in mutDFNA5, this shielding may not be
possible, leading to a constitutive activation of mutDFNA5 (Op
de Beeck et al., 2011).
In addition to HL, wild-type DFNA5 (wtDFNA5) has
also been correlated with several forms of cancer, such as
breast, colorectal, hepatocellular, and gastric cancer. Endogenous
DFNA5 is epigenetically silenced by hypermethylation in cancer
cells resulting in a decreased DFNA5 expression level. Based
on these findings, it is hypothesized that DFNA5 is a tumor
suppressor gene (TSG) (Akino et al., 2007; Kim et al., 2008a,b;
Wang et al., 2013).
The function of DFNA5 remained unknown for a long time,
but previous functional studies by Op de Beeck et al. (2011)
revealed that DFNA5 induces a growth defect in mutDFNA5-
transfected HEK293T cells, as well as other cells, leading to PCD
(Op de Beeck et al., 2011). The cell death-inducing capacity of
DFNA5 was not only restricted to human cell lines, but was
also observed in the yeast model Saccharomyces cerevisiae (Van
Rossom et al., 2012). This inspired us to use these two different
model organisms to further elucidate the mechanisms related to
DFNA5.
The Saccharomyces cerevisiae yeast model has several
advantages as a model organism compared to human cell lines.
The rapid growth, inexpensive media and the relatively easy
genetic modifications, made the budding yeast Saccharomyces
cerevisiae a valuable model to unravel regulators of different
human pathologies (reviewed in Winderickx et al., 2008). Thirty
percent of known genes involved in human diseases have an
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ortholog in yeast and due to this high degree of conservation,
yeast is very suitable for fundamental research to identify core
regulators of diverse signaling mechanisms (Foury, 1997). This
was demonstrated in particular for mechanisms related to PCD
where numerous yeast homologs of human genes related to cell
death have been identified to play a common role (Wissing et al.,
2004; Buttner et al., 2007; Madeo et al., 2009). The conservation
of PCD mechanisms has been confirmed for DFNA5-related
PCD in a previous study using the budding yeast Saccharomyces
cerevisiae (Van Rossom et al., 2012). This study demonstrated
the value of yeast to unravel PCD mechanisms-related to
human genes. Transformation of mutant DFNA5 (mutDFNA5)
in yeast led to the induction of PCD. Several mitochondrial
proteins, such as Fis1, Por1, Aac1 and Aac3, were shown to be
involved. Moreover, mutDFNA5 was found to co-localize with a
mitochondrial marker protein (Westermann and Neupert, 2000).
These former observations established a role for mitochondria
in DFNA5-related cell death in yeast and demonstrated the
value of yeast as a model organism to unravel DFNA5-related
(mitochondrial) HL.
In the current study, we performed a transcriptomic analysis
and confirmed the significance of mitochondria in DFNA5-
induced cell death in Saccharomyces cerevisiae. Additionally,
Gene Ontology (GO) analysis suggested a role for the
endoplasmic reticulum (ER). The latter observation was not
only present in Saccharomyces cerevisiae, but was also confirmed
in human cell lines. Furthermore, we show that the MAPK
pathways, namely the induction of the extracellular signal
regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), are
activated upon mutDFNA5 transfection in human cell lines.
Our data suggest the presence of a cellular adaptive response
related to mitochondria, MAPK pathways and potentially
for the ER. The exact correlation between those processes
and DFNA5 remains unclear but further study will lead
to a better understanding of DFNA5-induced cell death
mechanisms and to HL-related to mitochondrial damage in
general.
Material and Methods
Yeast
Yeast Strains and Growth Conditions
In this study, we used the BY4741 (MATa his311 leu210
met1510 ura310) wild-type strain (Brachmann et al., 1998).
Full-length cDNA of either wtDFNA5 or mutDFNA5was isolated
and amplified as previously described (Gregan et al., 2003).
Amplified products were ligated into yeast pYX212 plasmid
containing an HA-marker (Clontech, Mountain View, CA, USA)
using EcoRI and BamHI restriction sites. All constructs were
verified by bidirectional sequencing on an ABI genetic analyser
3130× l (AppliedBiosystems, FosterCity, CA, USA).
Yeast strains were grown at 30◦C in selective medium
containing 2% glucose (SD-URA). Fifty milliliter yeast cultures,
transformed with either wtDFNA5 or mutDFNA5, were
harvested in mid-exponential phase (OD600nm = 3.5 − 4.2)
and at the post-diauxic shift (OD600nm = 7.4 − 8.4) (Figure 1).
FIGURE 1 | Yeast microarray design. (A) Illustration of the different
comparisons that were made between the RNA samples. RNA was collected
from yeast strains transformed with either wtDFNA5 or mutDFNA5 at two
different time-points. The bold and dashed lines represent the color flip of each
RNA sample. (B) Growth profile of the Saccharomyces cerevisiae BY4741
background strain transformed with either wtDFNA5 (gray squares) or
mutDFNA5 (black squares). The blue and red ellipse illustrate respectively the
mid-exponential and post-diauxic time-points when RNA was collected.
Standard transformation techniques were applied for these
transformations (Gietz et al., 1992).
RNA Extraction Yeast
RNA was collected from yeast at mid-exponential phase and
just after the post-diauxic shift using RNA pure kit following
the manufactures instructions (GenHunter R© Corporation,
Nashville, TN, USA). All steps were performed in duplo at 4◦C
to avoid RNA degradation. This resulted in eight different RNA
samples: mid-exponential wtDFNA5, (WT_E1 and WT_E2),
mid-exponential mutDFNA5 (Mut_E1 and Mut_E2), post-
diauxic wtDFNA5 (WT_S1 and WT_S2), and post-diauxic
mutDFNA5 (Mut_S1 and Mut_S2) (Figure 1).
Microarray Design and Analysis
Microarray experiments were performed at the VIB Nucleomics
Core (www.nucleomics.be). Before labeling, RNA concentration
and purity were determined spectrophotometrically using the
Nanodrop ND-1000 (Nanodrop Technologies). RNA integrity
was assessed using a Bioanalyzer 2100 (Agilent). Per sample, an
amount of 1µg of total RNA spiked with 10 viral polyA transcript
controls (Agilent, Santa Clara, CA, USA) was converted to double
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stranded cDNA in a reverse transcription reaction. Subsequently,
the samples were converted to antisense cRNA, amplified and
labeled with Cyanine 3-CTP (Cy3) or Cyanine 5-CTP (Cy5) in
an in vitro transcription reaction according to the manufacturer’s
protocol (Agilent, Santa Clara, CA, USA). A mixture of purified
and labeled cRNA (Cy3 label: 5 pmol; Cy5 label: 3.5 pmol)
was hybridized on Agilent Yeastv2 arrays followed by washing,
according to the manufacturer’s procedures. To assess the raw
probe signal intensities, arrays were scanned using the Agilent
DNA MicroArray Scanner and probe signals were quantified
using Agilent’s Feature Extractor software (version 10.5.1.1).
In total four different comparisons were made. Each
comparison was done in duplo by a color flip. The different
comparisons are shown in Figure 1A. Gene expressions of
strains transformed with wtDFNA5 were compared to strains
transformed with mutDFNA5, both in mid-exponential phase
(comparison 1a) and at the post-diauxic shift (comparison
1b). Additionally, comparisons were made between the
mid-exponential and the post-diauxic shift of either wtDFNA5-
(comparison 2b) or mutDFNA5-(comparison 2a) transformed
cells.
Analysis of the microarray data was performed using the
R package LIMMA (http://www.bioconductor.org) (Gentleman
et al., 2004). Fold changes were computed using raw Cy3
and Cy5 intensities values provided by Agilent’s Feature
Extractor software (version 10.5.1.1) and loess normalization
and background correction were performed to determine the
log2-ratios per array. Differential expression was assessed via the
moderated t-statistic, described in (Smyth, 2004). To control the
false discovery rate, multiple testing correction was performed.
This generated four differentially expressed gene lists. All the
(raw) data files have been completely uploaded to the gene
expression omnibus and have been stored under accession
number GSE70169.
HEK293T Cells
Cell Culture and Growth Conditions
The microarray experiments in human cell lines were performed
using Human Embryonic Kidney 293T cells (HEK293T).
HEK293T cells were subcultured in 60mm dishes at a density of
2 × 106 cells in Dulbecco’s modified Eagle’s medium containing
4500 mg/L glucose supplemented with 10% (v/v) fetal calf
serum, 100 U/ml penicillin, 100µg/ml streptomycin, and 2mM
L-glutamine. Overnight cultures were transfected with either
control (empty EGFP vector), wtDFNA5 or mutDFNA5 using
lipofectamine. Six hours post transfection, cells were harvested
using Triple-x reagent for RNA extraction. All products for
human cell line cultures were obtained from Invitrogen (San
Diego, CA, USA). Full-length cDNA of either wtDFNA5 or
mutDFNA5 was isolated and amplified as previously described
(Gregan et al., 2003).
RNA Extraction
An RNeasy mini kit was used for RNA extraction from
transfected HEK293T cells (Qiagen, Hilden, Germany) at
different time-points. For the microarray experiment, RNA was
extracted 12 h post-transfection. For the gene analysis by real
time rtPCR, RNA was extracted at either 3, 6, 12, 15, 18, 20,
or 24 h post-transfection. For the microarray experiment, the
integrity of the resulting RNA was checked on an automated
Experion electrophoresis system (Biorad, Hercules, CA, USA).
Microarray Design and Analysis
The “Totalprep RNA Amplification” kit was used to amplify
the RNA samples (Illumina, Ambion, Austin, TX, USA).
Doublestranded-cDNA was generated from the mRNA fractions
followed by an in vitro transcription reaction which produced
cRNA strands containing biotin-UTP nucleotides. Seven
Hundred Fifty nano gram of the resulting cRNA samples were
hybridized to an Illumina human HT12v3 beadchip (Illumina,
San Diego, CA, USA).
Six independent biological replicates were used for either
wtDFNA5- or mutDFNA5-transfected HEK293T cells and loaded
on the chip. Overnight hybridization at 58◦C was followed
by washing and streptavidin-Cy3 dye labeling (Amersham,
Buckinghamshire, England). An Illumina Iscan equipped with
Iscan control software was used to measure the intensity values
and XY coordinates for every probe on the array. The resulting
data files were then analyzed using the R package “Beadarray
v1.14.0” (Dunning et al., 2007) followed by a quality control
and quantile normalization. LIMMA v3.2.1 was used for the
further analysis of the normalized intensity values to determine
the differentially expressed genes (Smyth, 2004).
All the (raw) data files have been completely uploaded to the
gene expression omnibus and have been stored under accession
number GSE70169.
Real Time rtPCR
To confirm the results obtained from the microarray data
in HEK293T cells, gene expression was studied in human
HEK293T cell lines using Power SYBR Green RNA-to CT 1 Step
Kit (Invitrogen, San Diego, CA, USA). Each reaction mixture
contained 200 nM final primer concentration (primer pairs are
shown in Supplemental Data Table 1) and 30 ng RNA template.
All reactions were performed in triplicate on a LightCycler
480 system (Roche, Basel, Switzerland) and resulting data were
analyzed by Qbase plus (Biogazelle, Ghent, Belgium). Three
housekeeping genes were used each time as a reference, namely
GAPDH, RPL13A, and YWHAZ.
Western Blot Analysis
For western blotting, cells were lysed using RIPA buffer (25mM
Tris-HCl (pH 7.6), 150mM NaCl, 1% NP-40, 1% sodium
deoxycholate, 0.1% SDS) (Pierce, Rockford, IL, USA) containing
a PhosSTOP Phosphatase Inhibitor Cocktail Tablet (Roche), an
EDTA-free protease tablet and 10µl (25 units/µl) benzonase
(70746-4 Novagen R©, Merck Millipore, Darmstadt, Germany).
Transfected HEK293T cells were lysed for 20′ at 4◦C and
centrifugated at 2000 g at 4◦C to obtain protein lysates.
Proteins were electrophoretically separated and blotted onto a
nitrocellulose membrane (Whatman, Kent, UK). This membrane
was blocked for 1 h in 5% non-fat dry milk and afterwards
incubated overnight (4◦C) in one of the following primary
antibodies: anti-phospho-SAPK/JNK (Thr183/Tyr185, #4668),
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anti-phospho-p44/42 (ERK1/2, #4370), anti-SAPK/JNK (#9252),
anti-p44/42 (ERK1/2, #9102) (Cell Signaling Technologies, MA,
USA), or anti-β-Actin (A5316, Sigma Aldrich, MO, USA). After
washing, the membranes were incubated with either a secondary
goat anti-rabbit (ab6721, Abcam, Cambridge, UK) or sheep
anti-mouse (NA931, GE Healthcare, Buckingmersham, UK)
antibody. Finally, the corresponding proteins were visualized
using Enhanced ChemiLuminescenceWestern Blotting Substrate
(Thermo Scientific, IL, USA).
MAPK Inhibition
The SP600125 JNK inhibitor was used to inhibit the MAPK
pathway. Twelve hours post-transfection, HEK293T cells were
incubated with 25µM for 12 h. Next, cells were collected and
viability was measured by flow cytometry (CyflowML, Partec,
Germany) using propidium iodide as a cell death marker.
Gene Ontology Analysis
In addition to the determination of the differentially expressed
genes, GO analysis was performed in order to identify enriched
GO annotations. We used an open-source application, the
Ontologizer, as a tool to statistically analyse the high-throughput
data (Ashburner et al., 2000). A standard method for statistics,
the “Term-for-Term analysis,” was used followed by Benjamini-
Hochberg correction for multiple testing (Hochberg and
Benjamini, 1990; Tavazoie et al., 1999). Differentially expressed
genes with a corrected p-value below 0.05 and a log2 (fold
change) of 1.5 and 0.5 in yeast and human cell lines respectively,
were selected for this analysis.
Results
To study the biological pathways of cell death induced byDFNA5
in S. cerevisiae, we performed a transcriptomic study. RNA
samples were collected in duplo in the mid-exponential phase
and at the post-diauxic shift of yeast cells transformed with either
wtDFNA5 of mutDFNA5. Figure 1 shows all the comparisons
studied between the different RNA samples (comparisons are
labeled 1a, 1b, 2a, and 2b). Analysis of the microarray data
was performed using the LIMMA package provided in R and
generated four lists of differentially expressed genes. For the
GO-enriched term analysis, the cut-off for adjusted p-values of
differentially expressed genes was set to 0.05 and the cut-off of
the log2 (fold change) was respectively set to 1.5 and 0.5 for yeast
and human cell lines.
Investigation of the differentially expressed genes in mid-
exponential phase (comparison 1a) revealed no significantly
up- or down-regulated genes. Therefore, this comparison was
excluded and only comparisons 1b, 2a, and 2b (shown in
Figure 1) will be taken into account and described.
Mitochondria-Related Processes are
Up-Regulated in mutDFNA5 in Post-Diauxic Shift
Comparison of the differentially expressed genes (adjusted
p < 0.05) in the post-diauxic shift (1b) resulted in 451
significantly up-regulated genes when expressing mutDFNA5
and using wtDFNA5 as a reference. The top 34 differentially
up-regulated genes at the post-diauxic shift are shown in Table 1.
Differentially expressed genes with a log2 (fold change) equal
or higher than 1.5 were selected for GO-enriched annotations,
generating 85 significantly up-regulated genes, which resulted in
65 significantly up-regulated enriched GO terms.
Analysis of the biological, cellular, and molecular GO
annotations confirmed the role of the mitochondria in
mutDFNA5-induced cell death (Supplemental Data Table
2, indicated in bold). Analysis of the GO annotations
revealed that the molecular cytochrome-c oxidase activity
(GO: 0004129) related process was the most significantly
up-regulated mitochondrial process. Further down the list,
several biological, molecular and cellular GO processes related
to mitochondrial mechanisms, such as mitochondrial ATP
synthesis-coupled electron transport (GO:0042775), aerobic
respiration (GO:0009060), the mitochondrial respiratory chain
(GO:0005746), mitochondrial respiratory chain complex IV
(GO:0005751), and oxidative phosphorylation (GO:0006119)
were significantly up-regulated suggesting mitochondrial
dysfunction (Supplemental Data Table 2).
Next we compared the identified GO terms with the
list containing the highest differentially up-regulated genes
generated by the R package LIMMA to evaluate the resemblances
(Table 1). As shown in Table 1, several mitochondrial genes
related to these GO processes were indeed present in the
list, including COX/1/2/3 and AI5_ALPHA (Table 1, bold).
COX1/2/3 are three main subunits of cytochrome c oxidase, the
terminal enzyme of the mitochondrial electron transport chain,
encoded by the mitochondrial genome. The electron transport
chain is part of mitochondrial oxidative phosphorylation
providing most of the cellular ATP (Srinivasan and Avadhani,
2012). AI5_ALPHA is an endonuclease encoding a mobile intron
of the COXI gene (Moran et al., 1992; Seraphin et al., 1992).
Up-regulation of the main COX genes suggests enhanced COX
activity, which has been associated with increased oxidative stress
(Singh et al., 2009; Srinivasan and Avadhani, 2012). Previous
data indeed demonstrated a change in redox homeostasis due
to mutDFNA5 expression in yeast (Van Rossom et al., 2012).
The same study also showed increased oxidative stress measured
by a dihydroethidium bromide staining (DHE). Moreover,
preliminary experiments in human cell lines confirmed this and
also revealed enhanced oxidative stress measured by a DHE
staining (unpublished results).
In addition, two other groups of significantly enriched GO
annotations could be distinguished, namely GO annotations
related to catabolic and metabolic energy processes, such as
oligosaccharide catabolic process (GO:0009313) or maltose
catabolic processes (GO:0000025), and mechanisms related to
transporter activity, such as cation (GO:0008324) and several
sugar (GO:0005353 for example) transmembrane activities
(Supplemental Data Table 2, respectively underlined and
indicated in blue). Consistent with the previous results,
comparison of these processes with the highest differentially
up-regulated genes in Table 1 confirmed these identified GO
terms (Table 1). Different maltose and sucrose genes likeMAL12,
MAL32, and SUC2, and transmembrane transporter genes like
HXT4/7 were present in the list (Table 1).
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TABLE 1 | Top 34 of the differentially up-regulated genes upon transfection of mutDFNA5 in yeast at the post-diauxic shift.
Gene name LogFC AveExpr adj.p.val Gene name LogFC AveExpr adj.p.val
MAL12 4.16 9.08 0.04 YOL047C 2.39 10.40 0.01
COX3 4.13 7.46 < 0.01 Q0297 2.38 7.24 0.01
MAL32 3.91 8.19 0.04 MND1 2.27 7.03 0.01
ANB1 3.60 9.59 0.01 VAR1 2.23 4.18 0.02
SLZ1 3.08 6.38 < 0.01 YPL141C 2.22 9.49 0.01
PRM7 3.07 11.62 0.01 HXT4 2.22 13.42 0.05
YPR077C 3.05 9.44 < 0.01 YNR034W-A 2.20 13.88 0.02
PRM7 3.04 11.01 0.01 YDR034W-B 2.17 9.17 0.02
HXT7 3.02 14.80 0.03 COX2 2.16 6.19 0.01
YDR374C 2.94 6.69 0.02 OLI1 2.15 15.96 < 0.01
YPL014W 2.89 8.59 0.02 YBL065W 2.15 6.87 0.01
AI5_ALPHA 2.89 10.49 0.04 SPR28 2.13 7.20 < 0.01
RTA1 2.83 7.90 < 0.01 COX1 2.12 7.77 0.01
YPR078C 2.65 7.06 < 0.01 DRE2 2.05 12.58 0.01
YLR194C 2.45 13.79 0.01 YKR075C 2.01 13.64 < 0.01
SUC2 2.44 11.79 0.04 YJL218W 2.00 6.92 0.04
SPO20 2.43 9.06 0.01 YLR338W 1.95 7.52 0.01
LogFC, logarithm of fold change, up-regulation in mutDFNA5 yeast samples using wtDFNA5 as a reference; adj.p.value, p-value adjusted for multiple hypothesis testing. Genes involved
in processes related to the COX activity are indicated in bold.
These results revealed an important role for mitochondria-
related processes in mutDFNA5 transformed yeast cells in the
post-diauxic shift.
Processes Associated with Glycolysis are
Down-Regulated in mutDFNA5 at Post-Diauxic
Shift
To investigate the significantly down-regulated processes
and genes in the post-diauxic shift between wtDFNA5 and
mutDFNA5, we used the same method as described in Section
Mitochondria-related Processes are Up-regulated in mutDFNA5
in Post-diauxic Shift. This revealed 585 significantly down-
regulated genes in cells expressing mutDFNA5 as compared to
those expressing wtDFNA5 (adjusted p < 0.05). The top 34
highest differentially down-regulated genes are shown in Table 2.
The significantly down-regulated biological GO annotations
can be divided in two main groups (Supplemental Data
Table 3). One group is related to ribosomal processes and
hence translation such as cytosolic ribosome (GO:0022626)
and the positive regulation of translation fidelity (GO:0045903)
(Supplemental Data Table 3, indicated in bold). This down-
regulation is probably due to the fact that yeast is entering
the post-diauxic shift and that mutDFNA5 has a growth defect
compared to wtDFNA5. Hence, this is probably not due to
mutDFNA5 expression. The second group was correlated with
the biosynthesis and metabolism of glucose (GO:0006007),
monosaccharide (GO:0046365) and glycolysis (GO:0006096).
Again, we compared the identified GO terms using the
list containing the highest differentially down-regulated genes
generated by the R package LIMMA to evaluate the resemblances
(Table 2). As expected, this list contained several components
associated with the glycolysis and several protein components of
the small and large ribosomal subunit.
Interestingly, the list also contained several genes such as TPI,
TDH2/3, PGK1, and CDC19, which are all enzymes playing a
role in either the glycolytic or the pentose phosphate pathway
(PPP) (Table 2 indicated in bold). CDC19 is the yeast homolog
of the human pyruvate kinase (PK) gene. Down-regulation of
PK has been correlated with the activation of the PPP and the
redirection of the metabolic flux from glycolysis to PPP both
in human cell lines and in yeast (Ralser et al., 2007; Christofk
et al., 2008; Anastasiou et al., 2011). This will enhance the anti-
oxidant response and hence increase the tolerance for oxidative
stress (Ralser et al., 2007; Gruning et al., 2011; Kruger et al., 2011).
The down-regulation of genes involved in glycolysis and the PPP
could suggest a link with oxidative stress providing a protection
mechanism for mutDFNA5-transformed yeast cells.
Induction of ER-Related Processes upon
mutDFNA5 Expression in Yeast
In addition to the comparison of mutDFNA5 and wtDFNA5
in the post-diauxic shift, the modifications between mid-
exponential phase and at the post-diauxic shift were investigated
separately both in mutDFNA5-(comparison 2a Figure 1) and
wtDFNA5-(comparison 2b Figure 1) transformed yeast cells. As
both wtDFNA5 and mutDFNA5 cells demonstrated differentially
expressed genes in exponential phase compared to post-diauxic
shift, we expected the presence of many significantly up- or
down regulated genes related to the post-diauxic shift but not
solely due to mutDFNA5 expression. Therefore, genes which
were differentially expressed at the post-diauxic shift upon
mutDFNA5 transformation, but do not show any differences
upon wtDFNA5 expression in post-diauxic phase, are potentially
related to mutDFNA5-associated processes. These were assigned
as mutDFNA5-related changes not associated with the post-
diauxic shift in yeast.
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TABLE 2 | Top 34 of the differentially down-regulated genes upon transfection of mutDFNA5 in yeast at the post-diauxic shift.
Gene name LogFC AveExpr adj.p.val Gene name LogFC AveExpr adj.p.val
ENO2 −3.00 16.12 0.01 ERG25 −1.77 14.05 0.05
SSA2 −2.68 14.66 0.01 YNR021W −1.74 11.30 < 0.01
VHT1 −2.54 13.48 0.02 YBT1 −1.73 12.67 0.05
DET1 −2.44 16.33 0.01 KAP122 −1.71 9.48 < 0.01
RPS22A −2.44 14.70 < 0.01 CDC19 −1.71 16.94 0.02
PGK1 −2.39 16.90 0.01 YDR509W −1.70 6.06 < 0.01
TDH3 −2.30 15.32 0.01 RPS9B −1.67 15.08 < 0.01
TPI1 −2.06 17.08 0.01 GNP1 −1.64 12.19 0.01
PDC1 −2.05 16.95 0.03 FTR1 −1.61 13.04 0.04
TDH2 −2.02 14.26 0.01 GPD1 −1.61 13.24 0.05
YHR140W −1.95 8.34 0.03 RPL16B −1.61 15.38 0.01
TOS4 −1.94 10.23 0.05 YGR266W −1.61 9.17 0.03
YRO2 −1.91 14.89 0.03 RPA43 −1.60 10.54 < 0.01
FBA1 −1.91 17.14 0.01 ARC1 −1.59 13.85 0.01
RPL9A −1.90 14.27 0.03 PGI1 −1.58 16.09 0.03
RPL22A −1.86 14.33 0.01 RPL18B −1.57 9.61 0.01
URA7 −1.83 12.90 < 0.01 SPE3 −1.56 12.70 0.01
LogFC, logarithm of fold change, down-regulation in mutDFNA5 yeast samples using wtDFNA5 as a reference; adj.p.value, p-value adjusted for multiple hypothesis testing. Genes
involved in processes related to the glycolysis or the pentose phosphate pathways are indicated in bold.
Genes with an adjusted p-value below 0.05 and a log2
(fold change) above 1.5 were selected for GO analysis.
The GO-enriched processes significantly associated with up-
regulated genes were very similar between comparison 2a and
2b and were associated with translation. GO-enriched terms
significantly associated with down-regulated genes were related
to ribosomes and RNA and were present both in wtDFNA5-
and in mutDFNA5-transformed yeast cells. These processes were
probably due to the shift to respiration and not in particular
related to mutDFNA5 (data not shown). However, three main
classes could be distinguished at the post-diauxic shift. Two
of them were more prominent in mutDFNA5-transformed
yeast cells. One class was related to the biosynthesis and
the metabolism of lipids (GO:0008610), such as (ergo)sterols
(GO:0016126), (phyto)steroids (GO:0006694), and fatty acids
(GO:0006633) (Supplemental Data Table 4, indicated in bold).
The other group was associated with the ER (GO:0005783), such
as the ER membrane (GO:0005789) and protein targeting to
ER (GO: 0045047) (Supplemental Data Table 4, processes are
underlined).
The third group which could be distinguished was related
to the cytoskeleton (GO:0005856) and was more pronounced
in wtDFNA5-transformed yeast cells. Cellularly enriched GO
terms such as the microtubule cytoskeleton (GO:0015630) and
the microtubule organizing center (GO:0005815) were present in
this list (Supplemental Data Table 5, indicated in bold).
Association of DFNA5 with the MAPK-Related
Mechanisms in HEK293T Cells
To further elucidate the DFNA5-related pathways, a microarray
experiment was performed in human HEK293T cells. As
described previously, mutDFNA5 induced a growth defect in
transfected HEK293T cells compared to wtDFNA5 and control
(cells transfected with an empty vector) (Op de Beeck et al.,
2011). These cell death events were evident from 9 h post-
transfection and peaked at 12 h (data not shown). Therefore
RNA samples of HEK293T cells were collected 12 h post-
transfection. A transcriptomic analysis was performed on
HEK293T cells transfected with either wtDFNA5 or mutDFNA5.
Six biological replicates of every RNA sample were collected
although one wtDFNA5-transfected sample did not survive
quality control. Subsequent analyses, using wtDFNA5 as a
reference, were therefore performed on five wtDFNA5- vs. six
mutDFNA5-transfected samples. Analysis using “Beadarray” and
“LIMMA” packages available in R identified 228 significantly
up- and 222 significantly down-regulated genes after correction
for multiple hypothesis testing (p < 0.05). In addition
to individual gene expression, GO analysis was performed
to determine the biologically, cellularly, and molecularly
enriched GO annotations linked to the differentially expressed
genes.
Table 3 shows the top 34 of the significantly up-regulated
genes. It contains several genes related to the MAPK
pathway such as EGR1/2, FOSB, andJUNB (indicated in
bold). Interestingly, this list also contained the PMAIP1
gene. PMAIP1 encodes a BH3-only protein belonging to
the BCL2 protein family, a family of important regulators
of apoptotic cell death related to the mitochondria. The
top 34 highest down-regulated genes are shown in Table 4
and contains several genes related to protein folding
such as HSPA6, ATF3, and CTH (indicated in bold,
Table 4).
Subsequent GO analysis of the biological annotations
revealed, in addition to the more general development processes,
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TABLE 3 | Top 34 of the significantly up-regulated genes in mutDFNA5 transfected HEK293T cells.
Gene symbol logFC AveExpr adj.p.val Gene symbol logFC AveExpr adj.p.val
ZCCHC12 2.63 12.07 <0.01 PMAIP1 (2750367) 1.00 10.76 <0.01
ETV5 1.88 9.11 <0.01 ETV4 0.99 7.71 <0.01
LOC387763 1.86 10.00 <0.01 SPRY2 0.97 9.96 <0.01
EGR1 1.83 11.82 <0.01 PMAIP1 (6020598) 0.96 9.30 <0.01
ARC 1.61 8.76 <0.01 CCNA1 0.94 7.60 <0.01
FOSB 1.58 8.85 <0.01 TRIM9 0.92 10.00 <0.01
KCTD12 1.40 10.32 <0.01 MAFF 0.90 7.95 <0.01
JUNB 1.40 9.09 <0.01 FAM84B 0.90 12.04 <0.01
ADAMTS1 1.24 9.88 <0.01 EPHA2 0.89 7.98 <0.01
EGR2 1.19 8.12 <0.01 CYP1B1 0.88 8.52 <0.01
FOS 1.18 10.17 <0.01 NDRG1 0.87 9.54 <0.01
CITED1 1.16 11.66 <0.01 SERTAD1 0.85 10.14 <0.01
MAFB 1.12 9.32 <0.01 MCL1 0.81 10.20 <0.01
GPR3 1.07 8.29 <0.01 SPRY4 0.81 7.66 <0.01
TNFRSF12A 1.06 9.77 <0.01 VGF 0.79 8.30 <0.01
TRIB1 1.04 11.60 <0.01 NEFM 0.79 11.58 <0.01
ANXA1 1.03 8.98 <0.01 GEM 0.79 7.88 <0.01
LogFC, logarithm of fold change, down-regulation in mutDFNA5 yeast samples using wtDFNA5 as a reference; adj.p.value, p-value adjusted for multiple hypothesis testing. The array
address of the specific splice variant on the microarray is provided between parentheses. Genes involved in processes related to either the MAPK pathway, cAMP response or the
mitochondria are indicated in bold.
TABLE 4 | Top 34 of the highest significantly down-regulated genes in mutDFNA5 transfected HEK293T cells.
Gene symbol logFC AveExpr adj.p.val Gene symbol logFC AveExpr adj.p.val
HSPA6 (160092) −1.54 10.49 <0.01 HRK −0.64 8.82 <0.01
DDIT4 −1.26 10.18 <0.01 C5orf13 −0.64 9.27 <0.01
CLEC2D −0.97 9.47 <0.01 LRAP −0.63 13.23 <0.01
ZNF256 −0.91 9.10 <0.01 CLEC2D −0.61 14.72 <0.01
TDP1 −0.87 10.90 <0.01 GUSBL1 −0.60 10.04 <0.01
LRP5L −0.84 8.76 <0.01 DTL −0.60 10.17 <0.01
CTH (60138) −0.80 10.40 <0.01 ZSCAN16 −0.58 8.66 <0.01
SNORD15B −0.78 8.76 <0.01 CTH (1470576) −0.58 8.75 <0.01
C17orf48 −0.76 8.45 <0.01 LOC654194 −0.58 13.17 <0.01
LOC389816 −0.73 8.57 <0.01 SNORD68 −0.58 10.17 <0.01
HSPA6 (1710553) −0.71 9.28 <0.01 ZNF205 −0.57 7.83 <0.01
ZMAT3 −0.70 12.59 <0.01 ZNF416 −0.57 8.56 <0.01
PMS2L3 −0.67 8.69 <0.01 LRRC26 −0.57 8.19 <0.01
PCDHGA9 −0.66 7.61 <0.01 Hs.537645 −0.57 7.54 <0.01
CTH (6220504) −0.65 8.29 <0.01 ATF3 (4780128) −0.56 11.95 <0.01
C3orf34 −0.64 12.64 <0.01 ACOT2 −0.55 9.15 <0.01
FANCE −0.64 9.35 <0.01 PCK2 −0.55 9.22 <0.01
LogFC, logarithm of fold change, down-regulation in mutDFNA5 yeast samples using wtDFNA5 as a reference; adj.p.value, p-value adjusted for multiple hypothesis testing. The array
address of the specific splice variant on the microarray is provided between parentheses. Genes involved in processes related to protein folding are indicated in bold.
the up-regulation of the MAPK pathway (GO:0043407) and
the cAMP response (GO:0051591) (Supplemental Data Table 6,
indicated in bold). The response to protein folding (GO:0006986)
and to topologically incorrect protein (GO:0035966) were the
only two significantly down-regulated processes and both were
related to protein folding (Supplemental Data Table 7). The most
important genes that are involved in these processes wereHSPA6,
a heat shock protein and several chaperones proteins, such as
DNAJB1 and DNAJB2.
These results demonstrate the association of mutDFNA5-
induced cell death with the MAPK pathways. The identification
of processes related to protein folding supports the results in yeast
in which GO terms related to protein folding and the ER were
significantly associated with mutDFNA5.
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Validation of the MAPK Role in DFNA5-Related
Cell Death in HEK293T Cells
The data generated by the transcriptomic analysis in HEK293T
cells were validated by real-time rtPCR of newly collected RNA
samples. EGR1 and FOSB gene expression was investigated on
different time-points ranging from 3 to 72 h post-transfection.
As shown in Figure 2, significantly up-regulated EGR1 and
FOSB gene expression was observed in cells transfected with
mutDFNA5 from 12 to 18 h post transfection (p < 0.05)
(Figure 2). Hence the data generated by the transcriptomic
analyses were indeed confirmed by real time rtPCR as
demonstrated by up-regulation of genes related to the MAPK
pathway.
After confirmation by real time rtPCR, the significance
of the activated MAPK pathway was further validated by
two independent experiments. To investigate the significance
of the MAPK pathway, we wondered whether inhibition of
the MAPK pathway would attenuate this mutDFNA5-induced
growth defect.
Therefore, a specific JNK inhibitor, namely SP600125, was
added, followed by a viability assay to determine the effect
on cell survival. Different concentrations of the JNK inhibitor
SP600125 were used to measure viability by flow cytometry
(CyFlow ML, Partec, Germany) and these results were compared
to untreated mutDFNA5-transfected HEK293T cells. Overnight
treatment of the cells with different concentrations of SP600125
did not have any major effect on transfection efficiency, but
significantly increased the viability of mutDFNA5-transfected
cells. Although, addition of 12.5 and 25µM SP600125 both
significantly increased the viability with a p-value of 0.020
and 0.004 respectively SP600125 had the greatest effect with a
concentration of 25µM SP600125 since the viability was raised
from 31.93 to 51.00% (Figure 3).
Next, to evaluate the effect of MAPK up-regulation on
protein level, different MAPK proteins were studied by
western blotting. There are three main MAPK pathways in
human cell lines represented by the ERK, JNK, and p38
MAPK branch. Consistent with the results obtained by real
time rtPCR and the viability assay, activation of the MAPK
pathway proteins was also demonstrated by western blotting.
Total protein lysates were collected from HEK293T cells 12 h
post-transfection. Three phosphorylated (activated) and non-
phosphorylated (not activated) proteins of the MAPK pathway
were studied using six different antibodies. No differences were
seen in the expression level of non-phosphorylated ERK and JNK
(Figure 4A). Activation of JNK and to a minor extent of ERK
(p42/p44) was seen upon mutDFNA5 transfection compared
to control and wtDFNA5 (Figure 4B). The expression of p38
was also evaluated but no difference in protein expression
was observed between mutDFNA5 compared to wtDFNA5 and
control (data not shown). β-Actin was used as a loading control.
These results suggest that DFNA5 induces PCD mediated
through activation of the MAPK pathways. Addition of a MAPK
inhibitor partially attenuated the mutDFNA5-induced growth
defect identifying the MAPK pathway as an early event in
mutDFNA5-associated cell death.
Comparison of the Yeast Microarray Results with
the Gene Expression in Human Cell Lines
In order to study the significance of the yeast results, a
comparison was made between the two microarray experiments.
Human homologs of the significantly up- and down-regulated
yeast genes at the post-diauxic shift (comparison 1b) were
identified using Ensemble Biomart. Of the 451 significantly up-
and 585 significantly down-regulated yeast genes, respectively
296 and 647 human homologs were identified. These specific
human homologs were analyzed using the R package LIMMA,
which generated a new list of human genes. The FC cut-off of
the resulting gene list was set to FC 1.2, resulting in 16 up- and
14 down-regulated human genes (Supplemental Tables 8A,B).
TM7SF2, UCP2, and VPS33B, three down-regulated human
genes, were selected to verify the yeast results in human cell
lines using real-time rtPCR. UCP2 and VPS33B were evaluated
because they were the two most down-regulated genes present in
FIGURE 2 | Increased EGR1 and FOSB gene expression in
mutDFNA5-transfected HEK293T cells. RNA samples were collected
from HEK293T cells transfected with either wtDFNA5 or mutDFNA5 and
gene expression was measured by real-time rtPCR. Significantly increased
expression was seen in mutDFNA5 at 12 h [p(egr1) = 0.000; p(fosB) =
0.006], 15 h [p(egr1) = 0.017; p(fosB) = 0.000] and 18 h [p(egr1) = 0.004;
p(fosB) = 0.026] post-transfection. *p < 0.05; **p < 0.01; ***p < 0.001.
CNRQ, calibrated normalized relative quantities.
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FIGURE 3 | MAPK inhibitor effect on mutDFNA5 transfected HEK293T cells. MutDFNA5-transfected HEK293T cells were pretreated with different amounts of
SP600125 (JNK inhibitor). Cell viability was measured and compared to untreated mutDFNA5-transfected HEK293T cells. *p < 0.05; **p < 0.01.
FIGURE 4 | Activation of the MAPK pathway by mutDFNA5. (A)
Western blot analysis of non- phosphorylated ERK (p42/p42) and JNK.
No differences were seen in protein expression level of ERK and JNK
between control, wtDFNA5 and mutDFNA5 transfected HEK293T cells.
(B) Western blot analysis of phosphorylated, activated ERK (p42/p42)
and JNK. Increased expression of JNK and to a lesser extent of ERK
was seen in mutDFNA5 transfected HEK293T cells as compared to
wtDFNA5 and control.
the list. UCP2, an uncoupling protein, is a mitochondrial carrier
located at the mitochondrial inner membrane. Suppression of
UCP2 has been linked to increased ROS production (Deng et al.,
2012; Dando et al., 2013) and lifespan regulation (Andrews and
Horvath, 2009; Andrews, 2010). The Vacuolar protein sorting
33 homolog (VPS33B) gene is involved in intracellular vesicle
Golgi-to-lysosome transport (Pevsner et al., 1996; Lo et al., 2005).
TM7SF2was selected based on its function in relation to the yeast
results. TM7SF2 is a transmembrane protein present in the ER
and associated with biosynthesis of cholesterol. In addition to its
role in cholesterol synthesis, TM7SF2 appears to be involved in
the inflammatory response upon cellular stress (Holmer et al.,
1998; Bennati et al., 2006; Schiavoni et al., 2010; Bellezza et al.,
2013).
To verify the yeast results in human cell lines, RNA
was collected from HEK293T cells transfected with either
wtDFNA5 or mutDFNA5 at different time-points starting at
12 h after transfection as this was the time-point of the human
microarray experiment. The TM7SF2, UCP2, and VPS33B genes
had a fold change of respectively 1.23, 1.31, and 1.27 on
the microarray. Real-time rtPCR on RNA samples 12 h post-
transfection confirmed these microarray results as all three genes
were down-regulated in mutDFNA5 compared to wtDFNA5
(Figure 5A) with fold changes comparable to the microarray
(respectively 1.35, 1.48, and 1.59). Although not significantly,
these three genes were down-regulated in HEK293T cells at 12 h
after transfection (Figure 5A). The down-regulation was still
present at 20 h, peaked at 24 h after transfection and was even
significant for TM7SF2 (p:0.01) andUCP2 (p:0.07) at respectively
20 h and 24 h after transfection (Figure 5B). Due to this down-
regulation, we can conclude that there are some similarities
between the yeast and the HEK293T microarray. Differences are
seen when looking at the individual genes, but upon study of the
different pathways a role for processes related to protein folding
were seen in both model systems.
Discussion
This study further investigated the biological effects induced by
DFNA5 expression in Saccharomyces cerevisiae and in human
HEK293T cells. A previous study in human cell lines revealed
that mutDFNA5 is a cell death-inducing gene (Op de Beeck
et al., 2011). As described previously (Van Rossom et al., 2012),
transformation of mutDFNA5 in yeast resulted in a growth defect
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FIGURE 5 | Validation of the yeast microarray by real-time rtPCR in
HEK293T cells. (A) Gene expression 12 h post-transfection in human
HEK293T cells of three selected genes. (B) Gene expression 12, 20, and
24 h post-transfection with either wtDFNA5 or mutant DFNA5. UCP2,
uncoupling protein 2 (mitochondrial, proton carrier); TM7SF2,
transmembrane 7 superfamily member 2; VPS33B, vacuolar protein sorting
33 homolog. Light gray, wtDFNA5; Dark gray, mutDFNA5. *p < 0.05. CNRQ,
calibrated normalized relative quantities.
associated with four different mitochondria-related proteins.
This study was the first to establish a possible link between
the mitochondria and DFNA5. In addition, the 2012 study
observed that the protein quality control system, responsible for
correct protein folding and degradation, had problems coping
with mutDFNA5. A failing protein quality control system could
indicate the presence of ER stress, as the ER can be involved in
protein folding and degradation.
This study confirmed the involvement of mitochondria-
related processes upon expression of mutDFNA5 in
Saccharomyces cerevisiae, especially the ATP-coupled electron
transport. Several genes related to either the glycolysis and
the PPP were significantly down-regulated upon mutDFNA5
transformation in yeast. Furthermore, we show that the JNK and
ERK MAPK pathways are activated in vitro after transfection of
mutDFNA5 in HEK293T cells and that inhibition of this pathway
is able to partially attenuate the resulting cell death. Additionally,
this study also revealed an association of GO annotations related
to the ER and protein folding in both model organisms.
Oxidative Stress and Hearing Loss
The up-regulation of different cytochrome c oxidase (COX)
genes revealed a potential association of the mutDFNA5-related
cell death mechanisms with oxidative stress in yeast. Increased
oxidative stress was already demonstrated in yeast (Van Rossom
et al., 2012) and was later confirmed in human cell lines
(unpublished results). Enhanced COX activity has indeed been
associated with increased oxidative stress (Singh et al., 2009;
Srinivasan and Avadhani, 2012). COX is the rate limiting enzyme
of respiration which regulates the bio-energetic status of the
cell. Dependent on the cellular energetic requirements, the COX
activity can be rapidly adapted. The ratio of ATP/ADP is one
of the regulators of the COX activity. High ADP levels or
ATP utilization will increase the enzyme activity and stimulate
the respiration (Napiwotzki and Kadenbach, 1998; Arnold and
Kadenbach, 1999). Activation of the COX activity could result in
higher oxidative stress generated at the mitochondria.
Additionally, the correlation of mutDFNA5 with several genes
of the PPP can also be linked to oxidative stress in yeast as the
PPP plays a major role in the anti-oxidant response. Reduced
expression of CDC19, the yeast homolog of PK, and of TPI has
been correlated with the activation of the PPP and the redirection
of the metabolic flux from glycolysis to PPP both in human cell
lines and in yeast (Christofk et al., 2008; Gruning et al., 2011,
2014). This study revealed reduced gene expression of both TPI
and CDC19, indicating a shift in redox sensing in eukaryotes
mediating a fast response to oxidative stress. Activation of the
PPP is correlated with the inhibition of ROS accumulation
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and enhancement of the anti-oxidant response upon shift from
fermentation to respiration. PPP activation will enhance the anti-
oxidant response and hence increase the tolerance for oxidative
stress (Ralser et al., 2007; Gruning et al., 2011; Kruger et al., 2011).
These data clearly demonstrate a change in redox homeostasis
due to mutDFNA5 expression which was shown previously in
yeast (Van Rossom et al., 2012).
Furthermore, enhanced oxidative stress is often related to a
failing protein quality control system (Davies, 2001; Shang et al.,
2001; Bender et al., 2010, 2011; Shang and Taylor, 2011). This
possibility was already suggested by the proteolytic degradation
previously seen upon wtDFNA5 transformation, but which was
absent in mutDFNA5-transformed yeast cells (Van Rossom et al.,
2012). MutDFNA5 seemed to escape this quality control system,
in contrast to wtDFNA5 which was subject to the normal
clearance system. Moreover, the authors suggested a possible
link between protein degradation and the mitochondria in
mutDFNA5-induced cell death as yeast seemed to have problems
with proper mutDFNA5 protein turnover. The same link was
confirmed in both model organisms used in the current study.
Role of ER Stress in the Pathology of Hearing
Loss
The increase in mitochondrial metabolism seen in this study and
the decrease of protein folding processes, can also be explained
by the presence of cellular ER stress leading to an unfolded
protein response. Mitochondria and ER form an interconnected
network which is important for several biological processes
mediating an adaptive response under various cellular stress
conditions (De Brito and Scorrano, 2010; Marchi et al., 2014).
The association betweenmutDFNA5 and the GO terms related to
lipid metabolism, protein targeting to ER and the ER membrane,
suggest the presence of ER stress (Schroder, 2008). Mitochondria
depend on the ER for the import of several proteins and lipids
and for Ca2+ exchange involved in cell death and mitochondrial
metabolism (Sauner and Levy, 1971; Zecchini et al., 2007; Stiban
et al., 2008;Wiel et al., 2014). Enhanced Ca2+ supply will increase
ATP production and mitochondrial respiration, processes which
were indeed both up-regulated at the post-diauxic shift upon
mutDFNA5 expression. Prolonged enhancement however will
eventually have a detrimental effect on the mitochondria.
Despite limited knowledge correlating mutDFNA5 with ER
stress, a correlation has been established between ER stress
and certain causes of HL. Ototoxicity (HL due to the use
of pharmaceuticals such as aminoglycoside antibiotics and
platinum-based chemotherapeutics) was shown to be correlated
with ER stress-dependent pathways. Certain pain relievers,
contributing to tinnitus and progressive bilateral sensorineural
HL, were shown to induce ROS overproduction, altered ER
morphology and changes in ER stress markers, such as CHOP
(Kalinec et al., 2014).
Taken together, the previous observation of the importance
of the mitochondria in mutDFNA5-related cell death and the
known correlation between the ER and the mitochondria points
to a potential role for the ER in DFNA5-induced cell death.
The failing of the protein quality control system in mutDFNA5
suggests the involvement of the ER, but this remains unclear at
this moment and needs to be further investigated in the future.
Contribution of the Mitochondria in
MAPK-Related Cell Death
In addition to the mitochondria, the MAPK pathways seem
to play a prominent role in mutDFNA5-induced cell death in
HEK293T cells. The link between the mitochondria and MAPK
in DFNA5-related cell death is unknown at this moment, but
several mitochondria-MAPK correlations have been described.
It is known that MAPK pathways can be induced by ROS
production generated by the mitochondria (Chambers and
Lograsso, 2011). As increased oxidative stress has been shown in
an earlier study in yeast and in human cell lines (unpublished
results), this can provide a direct link between these two
processes. This could suggest that ROS activates the MAPK
pathway and hence lays up-stream of the MAPK pathway in
DFNA5-induced cell death. However, we showed in this study
that a specific MAPK inhibitor was able to attenuate the cell
death and we have unpublished results showing that several anti-
oxidants did not inhibit DFNA5-induced cell death. This implies
that ROS is either a secondary event not directly causing cell
death, or that the activation of MAPK is an early event in the
cell death process, up-stream of ROS production. Furthermore,
comparison of yeast and the human microarray results identified
UCP2, a gene associated with the mitochondria, which showed
reduced gene expression in mutDFNA5 compared to wtDFNA5.
Interestingly, mitochondrial stress has been linked to the down-
regulation of UCP2 by activation of the MAPK pathway and
of JNK activation in particular (Emre et al., 2007; Selimovic
et al., 2008). UCP2 reduction was an early event required for
the amplification of the activated MAPK pathway enabling
mitochondrial ROS production (Emre et al., 2007; Basu Ball
et al, 2011). This down-regulation enables mitochondrial ROS
production providing the amplification loop stimulating the
MAPK pathway. UCP2 can therefore provide the link between
MAPK and the mitochondria, regulating the ROS production, a
feature deregulated in both model organisms.
However, we did not observe an up-regulation of MAPK-
related pathways in yeast. This could be explained by
the differences in timing between the experiments. For
human cell lines, the experiment was performed 12 h post-
transfection, while yeast RNA was collected at the post-diauxic
shift.
In conclusion, this study confirms the role of themitochondria
in mutDFNA5-induced toxicity in yeast. Additionally, it
shows that mutDFNA5-induced cell death is mediated by the
MAPK pathway, especially through the ERK and the JNK
branch. Inhibition of this pathway could significantly enhance
the cell viability of mutDFNA5-transfected HEK293T cells
which suggests the importance of this signaling cascade for
DFNA5. How the MAPK pathways perform their role in cell
death and the connection with DFNA5-related mechanisms
remains uncertain at this moment but is a good starting
for future studies. Future studies further unraveling the
DFNA5-induced cell death mechanism are important as
they may lead to new insights in the involvement of
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mitochondria in HL and have the potential to lead to new future
therapies.
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